
STROMUSC SR9009 10mg*100 For Bodybuilding CAS:1379686-30-2
SR9009, often dubbed "Exercise in a Pill," has generated significant buzz in bodybuilding circles despite its experimental status and murky legal/regulatory standing. Unlike traditional anabolic steroids or SARMs, SR9009 targets a fundamentally different pathway – the body's internal circadian clock – promising unique benefits. However, understanding it requires moving beyond hype and focusing on the underlying science and practical realities.
What is SR9009?
SR9009 is a synthetic compound classified as a REV-ERBα agonist. REV-ERBα is a nuclear receptor protein that acts as a critical transcriptional repressor, regulating the expression of numerous genes involved in core physiological processes:
●Circadian Rhythms: It's a core component of the molecular clock, governing daily cycles of sleep/wakefulness, metabolism, and hormone secretion.
●Metabolism: Regulates glucose and lipid metabolism, mitochondrial biogenesis, and inflammatory pathways.
●Immune Function & Inflammation: Modulates macrophage activity and inflammatory responses.
●Cellular Differentiation: Influences processes like adipogenesis (fat cell formation).
Developed primarily for research into metabolic disorders (like obesity and diabetes) and circadian rhythm disruptions, SR9009's potential to enhance endurance and body composition was discovered serendipitously in preclinical studies. Crucially, it has never been approved for human use by any major regulatory agency (FDA, EMA, etc.).


Features of SR9009 (The Circadian Edge)
SR9009's mechanism grants it distinct features setting it apart from common bodybuilding compounds:
●Non-Hormonal Action: It does not bind to androgen, estrogen, or growth hormone receptors. Its effects stem from altering gene expression via REV-ERBα.
●Circadian Modulation: Its primary action is intertwined with the body's master clock. Timing of administration relative to the body's natural rhythms may be crucial for optimal effects (though human data is lacking).
●Mitochondrial Focus: A core downstream effect is the significant upregulation of mitochondrial biogenesis and function. Mitochondria are the cellular powerhouses.
●Metabolic Reprogramming: Enhances oxidative metabolism (fat burning) while potentially suppressing glycolytic (sugar-burning) pathways, shifting energy utilization.
●Anti-Inflammatory Potential: REV-ERBα activation dampens inflammatory pathways, which could theoretically aid recovery.
●Poor Oral Bioavailability: A major limitation. Studies show very low absorption when taken orally (~5-10%), necessitating alternative routes (like sublingual) for any potential efficacy in humans, though data is anecdotal.
●Short Half-Life: Requires frequent dosing to maintain stable blood levels (see Half-Life section).
Applications in Bodybuilding (Theoretical & Anecdotal)
Based on its mechanism and animal studies, bodybuilders explore SR9009 for:
●Endurance Enhancement: Increased mitochondrial density and function directly translate to improved stamina, allowing for longer, more intense training sessions and potentially greater volume – a key driver of hypertrophy.
●Fat Loss Acceleration: By promoting oxidative metabolism (fat burning) and potentially inhibiting adipogenesis, it could create a more favorable environment for reducing body fat percentage while preserving muscle.
●Improved Recovery: Enhanced mitochondrial energy production and potential anti-inflammatory effects might reduce fatigue between sets and accelerate post-workout recovery, enabling more frequent high-intensity training.
●Muscle Preservation During Caloric Deficit: Increased reliance on fat for fuel and optimized energy metabolism could theoretically help spare muscle tissue when dieting.
●Circadian Optimization (Theoretical): Some speculate that timed dosing could align training and recovery phases with peak metabolic/circadian windows, though this remains highly speculative in humans.
Purported Benefits (Weighed Against Reality)
●Increased Exercise Capacity & Endurance: This is the most robustly supported benefit in animal models. Rats/mice showed dramatic increases (~50%) in running endurance. Human translation is unproven but is the primary driver of interest.
●Enhanced Fat Oxidation: Animal data supports increased metabolic rate and preferential fat burning. Anecdotal user reports often cite noticeable leanness and vascularity.
●Potential Muscle Hardness & Vascularity: Attributed to reduced subcutaneous water/fat and improved nutrient delivery via enhanced metabolism, rather than direct anabolism.
●Faster Recovery: Anecdotal reports suggest reduced muscle soreness and quicker readiness for subsequent workouts.
●No Androgenic Side Effects: No risk of hair loss, prostate issues, or virilization (in women) associated with steroids. No estrogenic side effects (gyno, water retention).
●Reportedly No HPTA Suppression: Unlike steroids and many SARMs, SR9009 appears not to suppress natural testosterone production significantly, based on limited anecdotal bloodwork and its non-hormonal mechanism. However, definitive human data is absent.
●Potential Cognitive Benefits (Speculative): REV-ERBα is expressed in the brain. Some users report improved focus/drive, possibly linked to metabolic/circadian effects.
Crucial Caveat: These benefits are primarily extrapolated from animal studies and user anecdotes. No rigorous, large-scale human trials confirm these effects for bodybuilding or any other application. Individual responses vary wildly.
Dosage & Cycle (Navigating the Unknown)
●Disclaimer: *There is no established safe or effective human dosage for SR9009. The following is based solely on prevalent, unverified anecdotal reports within the bodybuilding community. Self-administration carries significant risks.*
●Reported Dosage Range: 10mg to 30mg per day is commonly cited. Many start at 10-15mg to assess tolerance.
●Dosing Frequency: Due to its short half-life (see below), users typically split the daily dose into 2-4 administrations, roughly every 4-6 hours. Timing relative to workouts or circadian phase is highly speculative (e.g., some take doses pre-workout and upon waking).
●Administration: Due to poor oral bioavailability, sublingual administration (holding liquid under the tongue) is the most common anecdotal method used to try and bypass first-pass metabolism and improve absorption. Injections are mentioned but far less common and carry additional risks.
●Cycle Length: Typical anecdotal cycles range from 6 to 12 weeks. Longer cycles lack any safety data. A common rationale is aligning with the natural time course of mitochondrial biogenesis.
●"On" Time: There's no established need for time off specifically for HPTA recovery based on its mechanism. However, general principles of giving the body a break from any exogenous compound and financial cost often lead users to cycle it similarly to SARMs (e.g., 8 weeks on, 4-8 weeks off).
Half-Life (The Dosing Challenge)
●SR9009 has a notoriously short half-life, estimated to be in the range of 2.5 to 4 hours based on preclinical pharmacokinetic studies.
●Implications:
○Frequent Dosing Required: To maintain potentially effective blood concentrations and consistent REV-ERBα activation, dosing multiple times per day (at least 2-3x, often 4x) is necessary. This is a significant practical drawback.
○Peaks and Troughs: Even with frequent dosing, blood levels will fluctuate considerably, potentially leading to inconsistent effects.
○Overnight Gap: A long period without dosing overnight could theoretically reduce efficacy, conflicting with circadian goals.
Post Cycle Therapy (PCT)
●The Key Differentiator: Unlike anabolic steroids and many SARMs, SR9009 does not appear to suppress the Hypothalamic-Pituitary- Testicular Axis (HPTA) based on its non-hormonal mechanism and the limited available anecdotal bloodwork from users.
●PCT Recommendation: Generally not considered necessary. Most users report no significant drop in testosterone levels requiring SERM (like Tamoxifen/Clomid) or other PCT intervention after an SR9009-only cycle.
●Critical Considerations:
○Combination Cycles: If SR9009 is stacked with suppressive compounds (like RAD-140, Ligandrol, or actual steroids), a standard PCT for the suppressive compound is absolutely required. SR9009 itself doesn't negate the need for PCT in these scenarios.
○Individual Variance: Biology is complex. While suppression is unlikely, some individuals might experience minor hormonal fluctuations due to stress, diet, or other factors during the cycle. Post-cycle blood work is always the gold standard for assessing individual HPTA status, regardless of the compound.
○General Health: Supporting natural recovery with adequate sleep, nutrition (especially fats and cholesterol for hormone precursors), stress management, and potentially adaptogens (like Ashwagandha) is always beneficial post-cycle, even without formal PCT.
Clinical Data
|
Brand |
STROMUSC |
|
Trade names |
SR9011,Stenabolic |
|
CAS |
1379686-29-9 |
|
Molar mass |
479.04 |
|
MF |
C23H31ClN4O3S |
|
Purity |
Above 98% |
|
Apprarance |
10mg*100 |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-15871669785

Conclusion: Potential Tempered by Profound Uncertainty
SR9009 represents a fascinating departure from traditional performance-enhancing pathways, targeting the very core of our biological rhythms and metabolism. The potential benefits for bodybuilding – enhanced endurance, fat loss, recovery, and muscle preservation – are grounded in compelling preclinical biology. Its non-hormonal nature and apparent lack of HPTA suppression are significant advantages.
However, the leap from mice running longer on treadmills to humans building muscle is vast and largely uncharted. The lack of human clinical trials, poor oral bioavailability, short half-life demanding frequent dosing, undefined optimal timing relative to circadian rhythms, unknown long-term safety profile, and murky legal status create a landscape fraught with uncertainty and risk. Anecdotal reports exist but are unreliable and subject to placebo and confounding factors.
While SR9009 may offer a unique "circadian edge" in theory, it remains a research chemical with unproven efficacy and safety in humans. Bodybuilders considering its use must weigh the theoretical potential against the substantial unknowns and legal/sourcing risks. Extreme caution, rigorous personal research beyond marketing hype, and prioritizing health monitoring are non-negotiable. The quest for the "Exercise in a Pill" continues, but SR9009's role in that quest for humans remains definitively experimental.
Hot Tags: stromusc sr9009 10mg*100 for bodybuilding cas:1379686-30-2, China stromusc sr9009 10mg*100 for bodybuilding cas:1379686-30-2 manufacturers, suppliers, factory, GW0742 Hormone and Metabolic Regulators, SR9011, YK11, AC 262 Selective androgen receptor modulator, GW0742, SR9009
